Earnings Per Share, Basic of KalVista Pharmaceuticals, Inc. from 30 Apr 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
KalVista Pharmaceuticals, Inc. quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 30 Apr 2020 to 30 Sep 2025.
  • KalVista Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending 30 Sep 2025 was -0.92, a 9.5% decline year-over-year.
  • KalVista Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending 30 Sep 2025 was -4, a 11% decline year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2024 was -3.69, a 7.3% decline from 2023.
  • KalVista Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -3.44, a 3.3% decline from 2022.
  • KalVista Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -3.33, a 0.89% increase from 2021.
Source SEC data
View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

KalVista Pharmaceuticals, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 -4 -0.92 -0.08 -9.5% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 -3 -1.12 -0.25 -29% 01 May 2025 31 Jul 2025 10-Q 11 Sep 2025 2026 Q1
Q1 2025 -3 -1.06 0 0% 01 Feb 2025 30 Apr 2025 10-K 10 Jul 2025 2025 FY
Q4 2024 -3 -0.92 -0.08 -9.5% 01 Nov 2024 31 Jan 2025 10-Q 12 Mar 2025 2025 Q3
Q3 2024 -3 -0.84 -0.04 -5% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2025 Q3
Q2 2024 -3 -0.87 -0.13 -18% 01 May 2024 31 Jul 2024 10-Q 11 Sep 2025 2026 Q1
Q1 2024 -3 -1.06 -0.32 -43% 01 Feb 2024 30 Apr 2024 10-K 10 Jul 2025 2025 FY
Q4 2023 -3 -0.84 -0.09 -12% 01 Nov 2023 31 Jan 2024 10-Q 12 Mar 2025 2025 Q3
Q3 2023 -3 -0.8 +0.1 +11% 01 Aug 2023 31 Oct 2023 10-Q 05 Dec 2024 2025 Q2
Q2 2023 -3 -0.74 +0.2 +21% 01 May 2023 31 Jul 2023 10-Q 05 Sep 2024 2025 Q1
Q1 2023 -3 -0.74 +0.24 +24% 01 Feb 2023 30 Apr 2023 10-K 11 Jul 2024 2024 FY
Q4 2022 -3 -0.75 +0.17 +18% 01 Nov 2022 31 Jan 2023 10-Q 11 Mar 2024 2024 Q3
Q3 2022 -3 -0.9 -0.1 -12% 01 Aug 2022 31 Oct 2022 10-Q 07 Dec 2023 2024 Q2
Q2 2022 -3 -0.94 -0.28 -42% 01 May 2022 31 Jul 2022 10-Q 07 Sep 2023 2024 Q1
Q1 2022 -3 -0.98 01 Feb 2022 30 Apr 2022 10-K 11 Jul 2024 2024 FY
Q4 2021 -0.92 01 Nov 2021 31 Jan 2022 10-Q 09 Mar 2023 2023 Q3
Q3 2021 -0.8 01 Aug 2021 31 Oct 2021 10-Q 08 Dec 2022 2023 Q2
Q2 2021 -0.66 01 May 2021 31 Jul 2021 10-Q 08 Sep 2022 2023 Q1

KalVista Pharmaceuticals, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 -3.69 -0.25 -7.3% 01 May 2024 30 Apr 2025 10-K 10 Jul 2025 2025 FY
2023 -3.44 -0.11 -3.3% 01 May 2023 30 Apr 2024 10-K 10 Jul 2025 2025 FY
2022 -3.33 +0.03 +0.89% 01 May 2022 30 Apr 2023 10-K 11 Jul 2024 2024 FY
2021 -3.36 -0.94 -39% 01 May 2021 30 Apr 2022 10-K 11 Jul 2024 2024 FY
2020 -2.42 -0.78 -48% 01 May 2020 30 Apr 2021 10-K 10 Jul 2023 2023 FY
2019 -1.64 01 May 2019 30 Apr 2020 10-K 07 Jul 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.